Medications

FDA approves Regeneron's eye injection Eylea

(AP) -- Regulators on Friday approved Regeneron Pharmaceuticals Inc.'s drug Eylea, an injection designed to treat a common cause of blindness in older people.

Ophthalmology

Researchers probe genetic link to blindness

University of Leeds researchers have used next-generation DNA sequencing techniques to discover what causes a rare form of inherited eye disorders, including cataracts and glaucoma, in young children.

Ophthalmology

Novel drug to slow cataracts on their path to causing blindness

The innovators behind commercialising a world-first drug to slow cataract growth and to delay cataracts forming, have been named as one of five finalists in The University of Queensland (UQ) Business School's $100,000 Enterprize ...

page 5 from 5